BridgeBio to Participate in November and December Investor Conferences
PALO ALTO, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, today announced that members of its management team will participate in fireside chats at the following healthcare investor conferences:
Covered in this story
Call it yourself
No calls on $ALTO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Alto Ingredients →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.